Agilent Technologies has announced that the Wellcome Trust Case Control Consortium (WTCCC) will standardise the world’s largest human genomic copy number variation (CNV) study on Agilent microarrays. Agilent has also announced that IMGM Laboratories has achieved Certified Service Provider (CSP) status for the Agilent microarray platform.
IMGM is one of Europe’s leading genomic service providers and achieved Agilent-certified status after completing training and passing a rigorous series of assessments. These included demonstrating proficiency in, for example, analysing Agilent’s 60-mer oligo microarrays using the complete Agilent system, sample quality control using the Agilent 2100 bioanalyser, sample labelling using Agilent reagents and protocols, and final data analysis using the GeneSpring bioinformatics platform.
www. agilent.com